IP Verse

Isis Pharmaceuticals patent opposition analysis

Get complete Patent Opposition Report for Isis Pharmaceuticals

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest patents of Isis Pharmaceuticals opposed by its competitors

Explore Isis Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent Number	Grant Date	Title	Total Oppositions
EP2906696	Dec 14, 2022	Methods For Modulating C9Orf72 Expression	2
EP2742135	Jun 10, 2020	Linkage Modified Gapped Oligomeric Compounds And Uses Thereof	1
EP2399588	Apr 29, 2020	Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase	1
EP2640853	Dec 26, 2018	Modulation Of Alpha Synuclein Expression	1
EP2864479	Aug 15, 2018	Modulation Of Ube3A-Ats Expression	1
EP2701713	Feb 7, 2018	Modulation Of Apolipoprotein Ciii (Apociii) Expression	2
EP2812342	Nov 15, 2017	Modulation Of Rna By Repeat Targeting	1

Top competitors of Isis Pharmaceuticals

ROCHE INNOVATION CENTER COPENHAGEN

STRAWMAN

FHOFFMANN LA ROCHE